Parametric survival analysis of adjuvant therapy for stage II breast cancer
- 1 November 1994
- Vol. 74 (9) , 2483-2490
- https://doi.org/10.1002/1097-0142(19941101)74:9<2483::aid-cncr2820740915>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A model of long-term survival following adjuvant therapy for stage 2 breast cancerBritish Journal of Cancer, 1993
- Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinomaBritish Journal of Cancer, 1993
- The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trialBritish Journal of Cancer, 1992
- Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapyCancer, 1992
- The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiationBritish Journal of Cancer, 1992
- NSABP Trials of Adjuvant Chemotherapy for Breast CancerAnnals of Surgery, 1991
- Appraisal of Adjuvant Chemoendocrine Therapy with Tamoxifen Plus Tegafur in Patients with Breast Cancer.The Keio Journal of Medicine, 1991
- Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapyCancer, 1990
- Distribution of survival times of 12,000 head and neck cancer patients who died with their diseaseBritish Journal of Cancer, 1976
- A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteriBritish Journal of Cancer, 1975